Phase 1 Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older at the time of signing the consent form.
- People who have a confirmed diagnosis of endometrial cancer, epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer, based on tissue testing at a local lab.
- People who have received at least one previous course of chemotherapy treatment that included a platinum-based drug.
- People who have previously received a type of cancer drug called a PARP inhibitor, if their cancer is known to involve a change in the BRCA1 or BRCA2 gene.
- People who have measurable disease, meaning their cancer can be detected and measured on scans or tests.
- People who are willing to provide a stored tumour tissue sample.
- People whose general health and ability to carry out daily activities meets a specific standard, rated as 0 or 1 on a medical scale called the ECOG scale (confirm with trial site).
- People whose organs such as the liver, kidneys, and bone marrow are functioning well enough to meet the trial's requirements.
- People who have a specific genetic tissue type known as HLA-A*02:01 or HLA-A*02:02 (confirm with trial site).
- People whose tumour tests positive for a protein called PRAME.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or breastfeeding.
- People who have an uncontrolled bacterial, fungal, or viral infection.
- People who have an active infection that requires treatment with systemic medicines.
- People who have a bleeding or clotting disorder, or who are considered at high risk of serious bleeding.
- People who have any form of a condition where the immune system does not work properly from birth or by nature (primary immunodeficiency).
- People who have previously received a transplant of donor tissue or a solid organ.
- People who have an autoimmune disease that is currently active.
- People who are currently being treated with high-dose corticosteroid medicines taken throughout the body.
- People who still have unresolved side effects from a previous treatment.
- There may be additional exclusion criteria outlined in the full trial protocol (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Safety; Safety; Safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.